Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b1fe4d2a7b542fa44fc63767c8c07c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_043db3ed769dcb38c7c707680500752f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b88ada7c79789b3e454af5d3348c16db http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22932639aa504afebb70d17cc5bdf1b5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2004-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d5ee1318288276927b15768518b5e4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96fe87ae689e964e756230fd7e6a4981 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d415595b77ce3939a7533a07b7ad1da |
publicationDate |
2005-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005025545-A2 |
titleOfInvention |
Pharmaceutical formulation for controlled release of selodenoson |
abstract |
The present invention discloses a controlled release formulation suitable for oral administration comprising N6-cyclopentyl-5’-(N-ethyl)carboxamidoadenosine or a pharmaceutically acceptable salt or ester thereof incorporated in a controlled release matrix. The controlled release formulation of the invention is especially suitable for treating heart rhythm disturbances in a mammal. |
priorityDate |
2003-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |